We posit the latter observation is due to co-IP being markedly less sensitive than both the RIME and PLA methodologies and the ER+ breast cancer lines having substantially lower AR protein levels compared to the ER- lines (Additional file 2: Fig. S1F). This evidence concerns the gene ESR1 and breast carcinoma.